officialstreetpreachers Subscribe
Published: December 21, 2021

Medical journal roasts Facebook for censoring study that exposes problems with Pfizer’s COVID trial data

By The Editor

Tue Dec 21, 2021 – 4:46 pm EST

(LifeSiteNews) — The editors of the British Medical Journal (BMJ), “one of the world’s oldest and most influential general medical journals,” scorched Facebook fact checkers as “inaccurate, incompetent and irresponsible” Friday for determining that a landmark report they published exposing fraudulent practices in Pfizer’s COVID trial last month was “misleading.”

BMJ editor-in-chief Fiona Godlee and incoming editor-in-chief Kamran Abbasi penned an open letter to Facebook founder Mark Zuckerberg in response to claims by third-party “fact-checking” providers on the social media platform that claimed an article published by the BMJ on November 2 contained “false information” and was “missing context.”

The article in question, “COVID-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial” and authored by investigative journalist Paul D. Thacker, was commissioned by the BMJ after it began receiving insider information from a former regional director of the medical research company Ventavia in September.

Ventavia was hired by Pfizer in 2020 to conduct research for the pharmaceutical giant’s abortion-tainted mRNA COVID-19 shot.

According to the editors, the journal was prompted to hire an investigator after the whistleblower sent them “dozens of internal company documents, photos, audio recordings, and emails,” the contents of which “revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety.”

“We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA [Food

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors


Share this Article

Download the Mobile App.
Exit mobile version